Lv62
1760 积分 2023-11-09 加入
Risk Prediction for Clonal Cytopenia: Multicenter Real-World Evidence
3天前
已完结
A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions
15天前
已完结
A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions
1个月前
已完结
Cardiac events occurring after allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide. Study conducted on behalf of the GETH-TC
1个月前
已完结
Sirolimus and Cyclosporine With Post-Transplant Cyclophosphamide or Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Hematopoietic Cell Transplantation
1个月前
已完结
Validation of the 2025 IMS / IMWG risk classification in patients with newly diagnosed multiple myeloma treated with quadruplets and autologous stem cell transplant
1个月前
已完结
Opportunities and challenges for MRD assessment in the clinical management of multiple myeloma
2个月前
已完结
New age GVHD prophylaxis regimens: what works for what donor and why
2个月前
已完结
Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and Cyclosporin
2个月前
已完结
Opportunities and challenges for MRD assessment in the clinical management of multiple myeloma
2个月前
已完结
皖公网安备34019202002308
